For the above reasons, Medindia cannot be held liable for any action taken based on the information provided by its website. The purpose of this website is to provide initial guidance only and it does ...

For the above reasons, Medindia cannot be held liable for any action taken based on the information provided by its website. The purpose of this website is to provide initial guidance only and it does ...

New Delhi: France based multinational pharma company Sanofi has issued a circular in the Indian market stating that it is going to temporarily halt the sales of its Allegra Suspension syrup ...

The manufacturer said that it is voluntarily initiating a precautionary recall of these medicines from distributors, hospitals and retailers in the Indian market as a precautionary measure triggered ...

New Delhi, May 12: Drug major Sanofi is recalling four batches of its painkiller Combiflam in India after the country’s drugs regulator found the lots sub-standard. The company has taken the step ...

In the case of Combiflam, though the disintegration time was delayed, doctors and patients can be assured that there is no impact on the safety and efficacy of the product. Appropriate remedial steps ...

Central Drugs Standard Control Organisation (CDSCO) has directed its officials keep a strong vigil on the movement of Combiflam after batches of the drug was found substandard Central Drugs Standard ...

In a shocking development, specific batches of 60 drugs, some of which have been widely used, have failed quality tests in a sample-based screening conducted by the national drug regulatory agency ...

New Delhi [India], July 22 (ANI): French multinational pharma company Sanofi has issued a circular to all pharma distributors, hospitals and retailers in the Indian market regarding a "temporary halt" ...